TSC is a rare multisystem genetic disorder characterized by the development of tumors and caused by mutations in TSC1 or TSC2 genes, leading to dysregulation of the mammalian target of rapamycin (mTOR) pathway. This evidence concerns the gene MTOR and hereditary disease.